The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions
Linda M Collins, Susan A Murphy, Victor Strecher, Linda M Collins, Susan A Murphy, Victor Strecher
Abstract
In this article two new methods for building and evaluating eHealth interventions are described. The first is the Multiphase Optimization Strategy (MOST). It consists of a screening phase, in which intervention components are efficiently identified for inclusion in an intervention or for rejection, based on their performance; a refining phase, in which the selected components are fine tuned and issues such as optimal levels of each component are investigated; and a confirming phase, in which the optimized intervention, consisting of the selected components delivered at optimal levels, is evaluated in a standard randomized controlled trial. The second is the Sequential Multiple Assignment Randomized Trial (SMART), which is an innovative research design especially suited for building time-varying adaptive interventions. A SMART trial can be used to identify the best tailoring variables and decision rules for an adaptive intervention empirically. Both the MOST and SMART approaches use randomized experimentation to enable valid inferences. When properly implemented, these approaches will lead to the development of more potent eHealth interventions.
Figures

Source: PubMed
다가오는 임상 시험
-
Second Affiliated Hospital, Zhejiang University...아직 모집하지 않음
-
Institute of Hematology & Blood Diseases Hospital...아직 모집하지 않음산소 결핍 | 동종 조혈 줄기 세포 이식(HSCT) | 이식 기능중국
-
Centre Hospitalier Universitaire de Nice아직 모집하지 않음Dystrophic Epidermolysis Bullosa프랑스
-
Université Catholique de LouvainFonds Spécial de Recherche (FSR), UCLouvain모병
-
Alexandria University모병
-
Tongji Hospital아직 모집하지 않음간 재생 | Postoperative Liver Injury
-
Alexandria University아직 모집하지 않음
-
Lincoln University College아직 모집하지 않음Dental Trauma; Traumatic Dental Injury; Parent Education / Emergency Decision-Making
-
Zhihong LU아직 모집하지 않음
-
City of Hope Medical CenterNational Cancer Institute (NCI)아직 모집하지 않음두경부 편평 세포 암종 | 구인두 편평 세포 암종 | 임상 3기 HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | 3기 하인두 암종 AJCC v8 | 3기 후두암 AJCC v8 | III기 구인두(p16-음성) 암종 AJCC v8 | 하인두 편평 세포 암종 | 후두 편평 세포 암종 | 임상 1기 HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | 임상 II기 HPV 매개(p16 양성) 구강인두 암종 AJCC v8 | IVA기 하인두 암종 AJCC v8 | IVA기 후두암 AJCC v8 | IVA기 구인두(p16-음성) 암종 AJCC v8 | IVB 기... 그리고 다른 조건미국
-
The First Affiliated Hospital of Soochow University아직 모집하지 않음혈액 악성종양 | 급성 이식편대숙주병 | Haploidentical Peripheral Blood Stem Cell Transplantation